Divi's Laboratories Limited
NSE: DIVISLAB | Information Technology
Market Fundamentals
Stock Intelligence & News
Divi's Laboratories Limited
Divi's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication |SUBJECT: Copy of Newspaper Publication
Read Full Analysis →Divi's Laboratories Limited
Board Meeting Intimation |Meeting Date: 23-May-2026
Read Full Analysis →Divi's Laboratories Limited
Financial Results/Dividend |Meeting Date: 23-May-2026
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Pharma Q4 outlook mixed: Hospitals steady, generics face revlimid drag
Indian pharma and healthcare firms face a mixed March quarter. While hospitals anticipate steady growth, generic drugmakers grapple with lost Revlimid sales and pricing challenges. Lupin and Divi's are poised for strong performance, with Sun Pharma and Torrent showing resilience. Apollo Hospitals expects robust traction across its diverse segments.
Read Full Analysis →Divi's Laboratories Limited
Divi's Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 |SUBJECT: Certificate under SEBI (Depositories and Participants) Regulations, 2018
Read Full Analysis →Divi's Laboratories Limited
TYPE OF SECURITY : Equity Shares
Read Full Analysis →Divi's Laboratories Limited
Divi's Laboratories Limited has informed the Exchange about Closure of Trading Window |SUBJECT: Trading Window-XBRL
Read Full Analysis →Divi's Laboratories Limited
Divi's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |SUBJECT: Trading Window
Read Full Analysis →Divi's Laboratories Limited
Divi's Laboratories Limited has informed the Exchange about Draft Order issued under Section 144C(1) of the Income Tax Act, 1961 for FY2022-23. |SUBJECT: Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
Read Full Analysis →Divi's Laboratories Limited
Divi's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication |SUBJECT: Copy of Newspaper Publication
Read Full Analysis →Get instant alerts when DIVISLAB breaks news
Join investors who track Divi's Laboratories Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for DIVISLAB?
DIVISLAB is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Divi's Laboratories Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding DIVISLAB to your custom watchlist.